- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- February 2025
- 185 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- July 2024
- 189 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- July 2024
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- May 2025
- 114 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Report
- October 2024
- 200 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- April 2025
- 59 Pages
Global
From €2642EUR$2,950USD£2,252GBP
- Report
- September 2024
- 89 Pages
Global
From €4344EUR$4,850USD£3,703GBP
- Report
- August 2024
- 116 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- December 2024
- 151 Pages
Africa, Middle East
From €3090EUR$3,450USD£2,634GBP
- Report
- August 2019
- 264 Pages
Global
From €3578EUR$3,995USD£3,050GBP
- Report
- August 2022
- 121 Pages
Global
From €1164EUR$1,299USD£992GBP
- Report
- January 2022
- 151 Pages
Global
From €4298EUR$4,799USD£3,664GBP
- Report
- January 2024
- 270 Pages
Global
From €4298EUR$4,799USD£3,664GBP
- Report
- May 2024
- 311 Pages
Global
From €5282EUR$6,103USD£4,350GBP

Genome Editing is a technology used to make precise changes to the DNA of living organisms. It is used in a variety of applications, including gene therapy, crop engineering, and basic research. Genome Editing is a rapidly growing field within the genomics industry, as it allows for the manipulation of genetic material with unprecedented accuracy and speed.
Genome Editing is typically done using a variety of tools, such as CRISPR-Cas9, TALENs, and ZFNs. These tools allow for the insertion, deletion, or modification of specific DNA sequences. This technology has enabled researchers to make targeted changes to the genome of living organisms, allowing for the development of new treatments and therapies.
The Genome Editing market is expected to continue to grow in the coming years, as the technology is increasingly used in a variety of applications. Companies in the market include Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences, and Sangamo Therapeutics. Show Less Read more